Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples